Organogenesis, Fetal Circulation & Developmental Mechanisms

Organogenesis, Fetal Circulation & Developmental Mechanisms

Part 1 of 2 — Organogenesis, Extraembryonic Membranes & Fetal Circulation

Where this fits. The Early Embryology: Fertilization to Germ Layers lesson took the embryo from fertilization through gastrulation (the three germ layers) and the neural tube. This lesson follows it into organogenesis: the membranes and placenta that support it, how fetal blood bypasses the lungs and liver, then the potency, induction and signaling experiments that explain how cells choose their fates.

The Four Extraembryonic Membranes

The Placenta

The placenta is the interface between maternal and fetal circulations. Three functional headings:

1. Exchange: O₂, nutrients, and wastes cross by diffusion (and carrier transport) across the chorionic villi. Maternal and fetal blood do NOT mix — fetal capillaries sit inside villi that are bathed in maternal blood, always separated by cell layers.
2. Endocrine: hCG (first trimester, maintains corpus luteum), then placental progesterone and estrogen take over.
3. Immunity: maternal IgG crosses the placenta (the only antibody class that does), giving the newborn passive immunity.

Umbilical Vessels — The Naming Trap

Vessel names follow direction relative to the FETAL heart, not oxygen content:

• One umbilical VEIN carries OXYGENATED blood from the placenta TO the fetus.
• Two umbilical ARTERIES carry deoxygenated blood from the fetus back to the placenta.

This inverts the "arteries carry oxygenated blood" habit — the same inversion as the pulmonary vessels. It is one of the most reliably tested facts in this chapter.

The Three Fetal Shunts

The fetal lungs are fluid-filled and nonfunctional, and the liver is metabolically bypassable, so fetal circulation reroutes blood with three shunts:

Closure at birth: the first breath inflates the lungs, pulmonary resistance plummets, and left atrial pressure rises above right — the pressure reversal slams the foramen ovale's flap shut. Rising O₂ and falling prostaglandins constrict the ductus arteriosus. Clamping the cord ends flow through the ductus venosus.

• Adult remnants: foramen ovale → fossa ovalis; ductus arteriosus → ligamentum arteriosum; ductus venosus → ligamentum venosum.

Fetal Hemoglobin (HbF)

HbF (two alpha, two gamma subunits) binds 2,3-BPG poorly, so it holds O₂ more tightly than adult HbA — its dissociation curve is left-shifted. That affinity gap lets the fetus strip O₂ from maternal blood at the placenta.

Teratogens and the Critical Period

Organogenesis, roughly weeks 3-8, is when organ systems are being laid down — the window of maximum vulnerability to teratogens. Classic examples: thalidomide (limb defects), alcohol (fetal alcohol syndrome), rubella infection (heart/eye/ear defects). Before week 3, insults tend to be all-or-none (loss vs. full recovery); after week 8, teratogens cause mostly growth and functional deficits rather than gross structural malformations.

Apoptosis Builds Anatomy

Programmed cell death is a normal sculpting tool: the webbing between embryonic digits is removed by apoptosis to separate fingers and toes. Development uses death as deliberately as division.

• When this apoptosis fails, the digits stay webbed: syndactyly.

Worked Example — Following One Red Blood Cell Through the Fetus

Problem 1. An oxygenated red blood cell leaves the placenta and travels to the fetal brain. Trace its route, naming each shunt it uses.

• (a) In which vessel does it leave the placenta?
• (b) How does it get past the liver?
• (c) Which route takes it from the right atrium to the brain?
• (d) Where does fetal blood that does enter the right ventricle go?

(a) Leaving the placenta. The umbilical vein: the oxygenated vessel, despite being a vein, because vessel names follow direction relative to the fetal heart.

(b) Past the liver. Most flow diverts through the ductus venosus into the inferior vena cava, skipping hepatic capillaries so the well-oxygenated blood is not slowed or consumed by the liver.

(c) Through the heart. Much of the IVC stream crosses the foramen ovale into the left atrium, bypassing the right ventricle and the high-resistance lungs; then left ventricle → aorta → carotid arteries → brain. The freshest blood is steered to the brain and heart.

(d) The parallel path. Into the pulmonary artery, but high pulmonary resistance pushes most of it through the ductus arteriosus into the aorta: a second lung bypass, joining the aorta downstream of the head vessels.

Problem 2. After birth, a newborn's ductus arteriosus (fetal flow: pulmonary artery → aorta) fails to close (a patent ductus arteriosus, PDA). The first breath has already inflated the lungs and lowered pulmonary resistance.

• (a) Which way does blood now flow through the ductus?
• (b) What does this do to the pulmonary circuit?
• (c) Which drug class promotes closure, and why does it work?
• (d) When would a clinician want to keep the ductus open, and how?

(a) Direction. Aortic pressure now exceeds pulmonary pressure, so flow REVERSES from the fetal pattern: aorta → pulmonary artery, a left-to-right shunt.

(b) Effect on the lungs. Oxygenated blood recirculates through the lungs, volume-overloading the pulmonary circuit.

(c) Closing it. Prostaglandins keep the ductus open, so a prostaglandin synthesis inhibitor (an NSAID) promotes closure.

• The NSAID classically used to close a PDA is indomethacin.

(d) Keeping it open. When a heart defect makes the ductus temporarily life-saving (in pulmonary atresia, for example, the lungs receive blood only through the ductus), prostaglandin infusion holds it open. Every shunt question reduces to: what does it bypass, which pressures drive the flow, and what reverses at birth.

Membranes, Placenta & Fetal Circulation 🎯

Key Takeaways — Part 1

• Each membrane has a job. Amnion cushions; chorion forms the fetal placenta and makes hCG; yolk sac makes the first blood and germ cells.
• Placenta exchanges, never mixes. Villi exchange without blood mixing; hCG first, then placental progesterone/estrogen; IgG crosses.
• Three shunts, three bypasses. Ductus venosus skips the liver; foramen ovale (RA → LA) and ductus arteriosus (PA → aorta) skip the lungs.
• Teratogens strike weeks 3-8. Organogenesis is the window for structural defects (thalidomide, alcohol, rubella); earlier is all-or-none.

Common traps

• Umbilical arteries as oxygenated. Names follow the fetal heart: the single umbilical vein is oxygenated; the two arteries are not.
• Oxygen closes the foramen ovale. A pressure reversal (left atrium above right) shuts its flap; rising O₂ and falling prostaglandins close the ductus.
• HbF binding 2,3-BPG tightly. HbF binds 2,3-BPG poorly, so its curve is left-shifted and it pulls O₂ from maternal blood.
• A PDA shunting right to left. After birth an open ductus shunts left to right (aorta → pulmonary artery); NSAIDs help close it.

Low-yield extras

• Shunt remnants (fossa ovalis, ligamentum arteriosum, ligamentum venosum); indomethacin as the NSAID used to close a PDA; failed digit apoptosis = syndactyly.

Organogenesis, Fetal Circulation & Developmental Mechanisms

Part 2 of 2 — MCAT Integration: Potency, Induction & Experimental Embryology

This part builds on the Early Embryology: Fertilization to Germ Layers lesson: the germ layers, notochord and neural tube it traced are now the raw material for asking how a cell's fate gets fixed.

The Potency Hierarchy

Potency = the range of cell types a cell can still become. It only ever narrows during normal development:

iPSCs (induced pluripotent stem cells): adult somatic cells reprogrammed with transcription factors back to a pluripotent state — evidence that differentiation changes gene EXPRESSION, not gene content. The pluripotent/totipotent boundary is a favorite trap: ES cells cannot make placenta, so they are pluripotent, not totipotent.

Determination vs. Differentiation

• Determination: the cell COMMITS to a fate. It is invisible — the cell still looks generic — and it precedes differentiation. Test for it experimentally: transplant the cell somewhere new; a determined cell develops according to its ORIGINAL fate regardless of surroundings.
• Differentiation: the committed cell actually BUILDS the specialized phenotype — new proteins, new morphology (a myoblast making actin/myosin and fusing into a myotube).

Order: specification (reversible bias; a specified tissue follows its fate when cultured alone, but a conflicting environment can still change it) → determination (commitment) → differentiation (observable specialization).

Induction: Cells Telling Neighbors What to Become

Induction is one tissue directing the developmental fate of an adjacent tissue, usually via secreted paracrine signals. The signal-sender is the inducer; the receiver must be competent (have the receptors) to respond.

Two classic examples: the notochord (a midline rod of mesoderm) induces the overlying ectoderm to form the neural plate, the start of the nervous system; the optic vesicle (an outgrowth of the brain) induces the overlying surface ectoderm to form the lens of the eye.

The Organizer — Logic of a Legendary Experiment

A gastrula is an embryo undergoing gastrulation, the stage when cells move inward to form the three germ layers (ectoderm, mesoderm, endoderm). In amphibians they move in through the blastopore, an opening on the embryo's surface. Transplant the dorsal lip of the blastopore (its upper edge) from a donor newt gastrula onto the OPPOSITE (ventral) side of a host embryo. Result: a second, nearly complete body axis — a conjoined twin — forms at the graft site. The decisive observation: the second axis is built mostly from HOST cells.

• If the graft had simply developed into its own fated structures, the second axis would be donor-derived — that would show only self-differentiation.
• Because HOST cells were recruited and re-directed into neural tube and other axial structures, the graft must have been SIGNALING its neighbors: proof of induction. The dorsal lip was named the organizer.

• This is the Spemann-Mangold experiment (1924); the dorsal lip is also called the Spemann organizer.

Morphogens: Concentration Encodes Fate

A morphogen is a diffusible signal whose CONCENTRATION determines cell fate — cells near the source see high levels and adopt one fate; farther cells see less and adopt others: one gradient, several thresholds, several tissue stripes. A gradient explains how ONE signal specifies MANY fates — a single on/off signal could only specify two.

Name-level examples: Sonic hedgehog (Shh), secreted by the notochord and the ventral floor plate of the neural tube (the embryo's precursor of the brain and spinal cord), patterns the tube's ventral side (Shh also patterns the limb); BMPs from the overlying surface ectoderm pattern its dorsal side.

• This threshold picture is nicknamed the "French flag" model: one gradient read as three stripes.

The Experimentalist's Toolbox — What Each Design Can Conclude

Fate ≠ potency: lineage tracing reveals fate; only a challenge (transplant to a new environment) reveals potency.

Regulative vs. Mosaic Development — Closing the Loop

• Regulative development (indeterminate cleavage, in which the blastomeres made by the zygote's first rapid divisions are not yet committed, e.g., mammals): early cells can compensate — remove a blastomere and the rest regulate to form a whole embryo; split the embryo and get monozygotic twins. Fates are assigned largely by SIGNALING (conditional specification).
• Mosaic development (determinate cleavage, e.g., tunicates): fates are fixed early by localized cytoplasmic determinants; remove a blastomere and its structures are simply MISSING. No twinning by splitting.

Worked Example — Interpreting a Transplantation Table

Problem 1. In an amphibian gastrula, region X normally becomes epidermis and region Y neural tissue. Grafted into Y territory, X from an EARLY gastrula becomes neural tissue (Experiment 1); X from a LATE gastrula becomes epidermis (Experiment 2).

• (a) Was region X determined at the early stage?
• (b) Was region X determined at the late stage?
• (c) What changed X between the two stages, and what most likely caused it?

(a) Early X. No. In Experiment 1, early X adopted the fate of its new surroundings (neural), so its fate was still conditional: the host environment re-specified it. A determined tissue ignores its surroundings.

(b) Late X. Yes. In Experiment 2, late X kept making epidermis even inside neural territory, so its fate no longer depended on where it sat.

(c) What changed. Signals exchanged during gastrulation. Neural inducers from the organizer and notochord, acting near Y, re-specified early X in Experiment 1; ectoderm outside their reach is fixed as epidermis by the end of gastrulation.

Problem 2. In the same embryos (X normally epidermis, Y normally neural), Y from a LATE gastrula grafted into X territory still becomes neural tissue (Experiment 3). Late-gastrula X cultured ALONE in neutral medium becomes epidermis (Experiment 4).

• (a) What does Experiment 3 show about region Y?
• (b) What does Experiment 4 add to Experiment 2?
• (c) What would it mean if an isolated tissue stalled or switched to another fate?

(a) Region Y. Late Y also ignores its new location, so it is determined too. Determination happened tissue-wide during gastrulation, not in X alone.

(b) What isolation adds. Isolation removes every inducer, so it asks whether X's fate needs any outside signal at all. The graft (Experiment 2) asked the stronger question: does the fate resist conflicting signals? Late X passes both.

(c) The other outcome. The tissue would be not yet even specified: it still needed outside signals. Isolation tests specification; only a conflicting graft tests determination.

Potency, Induction & Experimental Design 🎯

Key Takeaways — Part 2

• Potency only narrows. Totipotent cells also make trophoblast; pluripotent ICM/ES cells make all three germ layers; multipotent, one family.
• Determination, then differentiation. Commitment is invisible and tested by transplant; differentiation is the visible build-out that follows.
• Induction needs a competent responder. A signal redirects only neighbors able to respond; the organizer's host-built second axis proves induction.
• Morphogens set fate by dose. One gradient read at several concentration thresholds specifies several fates (Shh, BMP).

Common traps

• ES cells as totipotent. ES cells cannot make trophoblast (placenta), so they are pluripotent, not totipotent.
• Lineage tracing shows potency. Tracing reveals only a cell's normal fate; potency needs a challenge, such as a transplant.
• Ablation proves sufficiency. Removing a tissue shows it is necessary for a structure, never that it is sufficient.
• Mosaic embryos compensating. Mosaic embryos lose a removed blastomere's structures; regulative ones compensate and can twin.

Low-yield extras

• The organizer experiment's eponym (Spemann-Mangold, 1924; the "Spemann organizer"); the "French flag" nickname for threshold-based morphogen patterning.